"AMBS" - Amarantus Bioscience -Most undervalued stock in the market. Under a dime. Working with Becton Dickinson developing diagnostic test to detect early stage Alzheimer's. Commecialization in 2014.
Company's patented drug, MANF, already has two orphan indication: one for Retinitis Pigmentosa and one in the field of diabetes.
Planned uplisting to the NASDAQ this year.
Over 13,000,000 shares sold short the last three sessions as the shorts try to keep the share price under a dime.
Imagine what happens to the share price when a partnership wit Becton Dickinson is announced. :)
The "Eve of Destruction".
The last three trading sessions to keep the price under a dime. That was without any news.
Imagine what happens when substantial news is released.
Happy New Year ahead for the AMBS shareholders. :)
Not surprising that there was profit taking today especially when there was no news.
The short volume yesterday was over 5,000,000 shares and I would imagine today's was comparable.
Over 13,000,000 shares traded today and it almost closed at .08 which is almost double what it was a few weeks ago.
The stock continues to be under accumulaion as word gets out to the market.
2014 will be a very good year for the AMBS shareholders.
As Ripley said, "Believe it or not?"
If he's correct the share price goes to .50.
Place your bets.
I know of three individual who shorted a total of over a million shares at .051. They covered at .062. Went long at .065 and are still holding their shares.
Sooner than expected.
Shorts get burned and the penny flippers get left behind.